My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
11.91
-0.75 (-5.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,725,165
Open
12.76
Bid (Size)
11.88 (9)
Ask (Size)
12.02 (2)
Prev. Close
12.66
Today's Range
11.90 - 12.84
52wk Range
4.700 - 13.09
Shares Outstanding
38,595,310
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MindMed Announces New Employee Inducement Grant
October 14, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression
October 13, 2025
Needham starts MindMed at Buy with a $28 target, citing strong Phase 3 prospects for MM120 in anxiety and depression and solid cash position.
Via
Benzinga
Performance
YTD
+58.0%
+58.0%
1 Month
+22.7%
+22.7%
3 Month
+34.1%
+34.1%
6 Month
+106.4%
+106.4%
1 Year
+83.5%
+83.5%
More News
Read More
The Insider Report: Panic Never Pays
October 11, 2025
Via
Benzinga
MindMed Announces New Employee Inducement Grants
September 22, 2025
From
Mind Medicine Inc.
Via
Business Wire
Earnings Scheduled For July 31, 2025
July 31, 2025
Via
Benzinga
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
September 19, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grants
September 08, 2025
From
Mind Medicine Inc.
Via
Business Wire
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)
September 04, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Participate in September Investor Conferences
August 28, 2025
From
Mind Medicine Inc.
Via
Business Wire
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today
August 12, 2025
Via
The Motley Fool
MindMed Announces New Employee Inducement Grants
August 11, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed (MNMD) Q2 2025 Earnings Call Transcript
August 11, 2025
Via
The Motley Fool
Topics
Earnings
Initial Public Offering
MindMed Reports Strong Q2 2025 Results
August 11, 2025
Via
The Motley Fool
1 Reason to Buy MindMed (MNMD)
August 07, 2025
Via
The Motley Fool
Topics
Cannabis
Law Enforcement
MindMed (MNMD) Q2 Net Loss Jumps 625%
August 01, 2025
Via
The Motley Fool
Topics
Intellectual Property
MindMed Reports Q2 2025 Financial Results and Business Updates
July 31, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025
July 24, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grants
July 14, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grants
June 09, 2025
From
Mind Medicine Inc.
Via
Business Wire
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Why Mind Medicine Gave Investors a Powerful Buzz in May
June 04, 2025
Via
The Motley Fool
Topics
Law Enforcement
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
Via
FinancialNewsMedia
Topics
Death
MindMed to Participate in June Investor Conferences
May 28, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer
May 27, 2025
From
Mind Medicine Inc.
Via
Business Wire
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
Via
Benzinga
Topics
Government
Frequently Asked Questions
Is Mind Medicine (MindMed) Inc. - Common Shares publicly traded?
Yes, Mind Medicine (MindMed) Inc. - Common Shares is publicly traded.
What exchange does Mind Medicine (MindMed) Inc. - Common Shares trade on?
Mind Medicine (MindMed) Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mind Medicine (MindMed) Inc. - Common Shares?
The ticker symbol for Mind Medicine (MindMed) Inc. - Common Shares is MNMD on the Nasdaq Stock Market
What is the current price of Mind Medicine (MindMed) Inc. - Common Shares?
The current price of Mind Medicine (MindMed) Inc. - Common Shares is 11.91
When was Mind Medicine (MindMed) Inc. - Common Shares last traded?
The last trade of Mind Medicine (MindMed) Inc. - Common Shares was at 10/16/25 04:00 PM ET
What is the market capitalization of Mind Medicine (MindMed) Inc. - Common Shares?
The market capitalization of Mind Medicine (MindMed) Inc. - Common Shares is 459.67M
How many shares of Mind Medicine (MindMed) Inc. - Common Shares are outstanding?
Mind Medicine (MindMed) Inc. - Common Shares has 460M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.